Researchers Develop Potent CDK9 Inhibitor to Overcome Drug Resistance in Hematological Malignancies (IMAGE)
Caption
In vivo efficacy evaluation of IHMT-CDK9-24 in mouse models of different hematologic malignancies.
Credit
SHI Chenliang
Usage Restrictions
no
License
Original content